Rosenthal J H, Pfeifle B, Michailov M L, Pschorr J, Jacob I C, Dahlheim H
Hypertension. 1984 May-Jun;6(3):383-90. doi: 10.1161/01.hyp.6.3.383.
Investigations were performed on components of the renin-angiotensin system (RAS) in homogenate extracts of vascular tissue and aortic smooth muscle cells cultivated in vitro. Determinations of isoelectric points and pH optima indicated the existence in aortic homogenate extracts of two local angiotensin I (AI)-forming enzymes (AIFE) that were different from those of plasma, renal cortex, veins, and aortic smooth muscle cells. The pH optima for AI-converting enzyme (ACE) from vascular tissues, aortic smooth muscle cells, and plasma were in the same range (pH 8.0-8.5), and in agreement with those measured previously in other tissues. In contrast, in vitro studies with the ACE inhibitors MK-421 and MK-422 and measurement of isoelectric points suggested that aortic ACE was different from the plasma enzyme. AIFE and ACE activities were found to be elevated in spontaneously hypertensive rats (SHR). The biochemical characteristics of the enzymes investigated in the vascular tissue of SHR were not different from those of the normotensive controls. AI- and AII-degrading enzymes were found both in aortic tissue and in aortic smooth muscle cells. One potent AI-degrading enzyme different from ACE was observed in aortic tissue. A high ratio of AI/AII immunoreactivities in arterial walls suggests the availability of renin substrate, and that AI-degrading enzymes are the rate-limiting enzymes for AII formation. The results further support the concept of an intrinsic vascular RAS.
对体外培养的血管组织匀浆提取物和主动脉平滑肌细胞中的肾素 - 血管紧张素系统(RAS)成分进行了研究。等电点和最适pH值的测定表明,主动脉匀浆提取物中存在两种与血浆、肾皮质、静脉和主动脉平滑肌细胞中的不同的局部血管紧张素I(AI)形成酶(AIFE)。来自血管组织、主动脉平滑肌细胞和血浆的AI转换酶(ACE)的最适pH值在相同范围内(pH 8.0 - 8.5),与先前在其他组织中测得的一致。相比之下,用ACE抑制剂MK - 421和MK - 422进行的体外研究以及等电点测量表明,主动脉ACE与血浆酶不同。发现自发性高血压大鼠(SHR)中AIFE和ACE活性升高。在SHR的血管组织中研究的酶的生化特性与正常血压对照的酶没有差异。在主动脉组织和主动脉平滑肌细胞中均发现了AI和AII降解酶。在主动脉组织中观察到一种不同于ACE的强效AI降解酶。动脉壁中AI/AII免疫反应性的高比率表明肾素底物的可用性,并且AI降解酶是AII形成的限速酶。这些结果进一步支持了血管内源性RAS的概念。